NeuroPace, Inc. (NPCE) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Medical - Devices industria. La empresa tiene su sede en Mountain View, CA, United States. El CEO actual es Joel D. Becker.
NPCE tiene fecha de IPO 2021-04-22, 184 empleados a tiempo completo, cotiza en el NASDAQ Global Market, una capitalización de mercado de $516.79M.
NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and enables clinicians to monitor patients in person and remotely. It sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. The company was incorporated in 1997 and is headquartered in Mountain View, California.
